99780-97-9Relevant articles and documents
PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS
-
Paragraph 0238; 0239, (2019/09/16)
The disclosure relates to compounds of Formulae (I)-(IX), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
N-type calcium channel blockers
-
Page/Page column 24, (2008/06/13)
The invention relates to novel 3-amino pyrrolidine derivatives, as well as methods for modulating calcium channel activity and for treating conditions associated with calcium channel function. In particular, the compounds generally contain at least one be
Conformationally Restricted Inhibitors of Angiotensin Converting Enzyme: Synthesis and Computations
Thorsett, Eugene D.,Harris, Elbert E.,Aster, Susan D.,Peterson, Elwood R.,Snyder, James P.,et al.
, p. 251 - 260 (2007/10/02)
A series of inhibitors of angiotensin converting enzyme (ACE, dipeptidyl carboxypeptidase, EC 3.4.15.1) is described which addresses certain conformational aspects of the enzyme-inhibitor interaction.In this study the alanylproline portion of the potent A